Company Filing History:
Years Active: 2017-2025
Title: Innovations and Contributions of Zhongjun Li
Introduction
Zhongjun Li is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biochemistry and pharmaceuticals, holding a total of 4 patents. His work focuses on the development of innovative compounds with potential medical applications.
Latest Patents
Zhongjun Li's latest patents include a method for preparing a fucosylated chondroitin sulfate oligosaccharide. This oligosaccharide has a specific structure that allows it to be applied in the medical field. The preparation method involves using a chondroitin sulfate A salt as a raw material, followed by enzymolysis, group protection operations, and glycosylation to synthesize the oligosaccharide compound. Another notable patent involves the use of aza-tryptanthrin derivatives as inhibitors of IDO1 and/or TDO. These derivatives have shown inhibitory effects on indoleamine-2,3-dioxygenase 1 (IDO1) and can be utilized in treating various diseases, including tumors, autoimmune diseases, and Alzheimer's disease.
Career Highlights
Zhongjun Li has worked with esteemed institutions such as Peking University and Boe Technology Group Co., Ltd. His experience in these organizations has contributed to his expertise in the field of innovation and invention.
Collaborations
Zhongjun Li has collaborated with notable colleagues, including Xiangbao Meng and Jiliang Wang. Their joint efforts have further advanced research and development in their respective areas of expertise.
Conclusion
Zhongjun Li's innovative work and patents reflect his dedication to advancing medical science. His contributions have the potential to impact various therapeutic areas significantly.